NCT04294472Phase 2Completed

A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients

Study sponsor: Vera Therapeutics, Inc. · VERA

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2022-02-10Actual
Enrollment · participants30Actual
Source updated2023-06-07Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.